Efficacy and Safety of Bevacizumab in the Neodjuvant Treatment of Inflammatory Breast Cancer
Status:
Unknown status
Trial end date:
2017-04-01
Target enrollment:
Participant gender:
Summary
Multi-center, non randomised, open label, non controlled pilot study. Evaluating the
treatment of bevacizumab in association with pre-operative chemotherapy, followed by surgery,
adjuvant chemotherapy and radiotherapy in Patients with inflammatory breast cancer.